The Suppressive Effect of Resveratrol on HIF-1α and VEGF Expression after Warm Ischemia and Reperfusion in Rat Liver

Background: Hypoxia-inducible factor-1 alpha (HIF-1 alpha) is overexpressed in many human tumors and their metastases, and is closely associated with a more aggressive tumor phenotype. The aim of the present study was to investigate the effect of resveratrol (RES) on the expression of ischemic-induced HIF-1 alpha and vascular endothelial growth factor (VEGF) in rat liver. Methods: Twenty-four rats were randomized into Sham, ischemia/reperfusion (I/R), and RES preconditioning groups. I/R was induced by portal pedicle clamping for 60 minutes followed by reperfusion for 60 minutes. The rats in RES group underwent the same surgical procedure as I/R group, and received 20 mg/kg resveratrol intravenously 30 min prior to ischemia. Blood and liver tissue samples were collected and subjected to biochemical assays, RT-PCR, and Western blot assays. Results: I/R resulted in a significant (P<0.05) increase in liver HIF-1 alpha and VEGF at both mRNA and protein levels 60 minutes after reperfusion. The mRNA and protein expressions of HIF-1 alpha and VEGF decreased significantly in RES group when compared to I/R group (P<0.05). Conclusion: The inhibiting effect of RES on the expressions of HIF-1 alpha and VEGF induced by I/R in rat liver suggested that HIF-1 alpha/VEGF could be a promising drug target for RES in the development of an effective anticancer therapy for the prevention of hepatic tumor growth and metastasis.